Critical Path Institute Announces New Board Members Critical Path Institute (C-Path) is proud to welcome four new board members who were recently elected to serve three-year terms (2
Critical Path Institute Honors World Tuberculosis Day 2012 Tuberculosis (TB) is often thought to be a disease of the past. The reality: Because no new therapies for TB have been developed i
Could Genetics Improve Warfarin Dosing? In a large-scale study and an upcoming clinical trial, scientists supported by the National Institutes of Health address one of th
Critical Path Institute Announces New CEO Critical Path Institute (C-Path) announced today that Dr. Carolyn Compton has joined the organization as its new president and chi
European Medicines Agency Deems Imaging Biomarker a Qualified Measure to Select Patients with Early Stages of Cognitive Impairment for Alzheimer’s Disease Clinical Trials Based on a request for regulatory review by Critical Path Institute’s (C-Path) Coalition Against Major Diseases (CAMD), the
C-Path Recognized in One of The National Institute of Mental Health’s Top 10 Research Advances of 2011
Critical Path Institute and Hamner Institutes for Health Sciences Announce Collaboration to Improve Safety of Medical Product Development Critical Path Institute(C-Path)and The Hamner Institutes for Health Sciences (The Hamner) announced today that they have signed a
January 12, 2011 Patient Self-report for Evaluating Mild Cognitive Impairment and Prodromal Alzheimer’s Disease
